ACBM ACRO BIOMEDICAL CO., LTD.

CIK 0001622996 3 ready 8-Ks latest January 8, 2026, 6:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline Risk accumulating: auditor change (2)

Ready 8-Ks 3

Latest filing January 8, 2026, 6:59 PM ET

Top materiality 0.70

Event mix other_material ×1 · leadership ×1 · other ×1

Sentiment 0 pos · 1 neg · 2 neu

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for ACBM

Highest-materiality recent filing

ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns

August 14, 2025, 7:59 PM ET leadership materiality 0.70 neutral item 5.02

Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.

January 8, 2026, 6:59 PM ET other material materiality 0.60 negative item 4.01 item 9.01 ◈ Auditor Changes ×2

Acro Biomedical dismisses auditor KCCW, engages Weinberg & Company

Dismissed KCCW Accountancy Corp. as independent auditor on January 4, 2026; no disagreements on accounting principles.
August 14, 2025, 7:59 PM ET leadership materiality 0.70 neutral item 5.02

ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns

Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
July 2, 2025, 7:59 PM ET other materiality 0.30 neutral item 4.01 item 9.01 ◈ Auditor Changes ×2

Acro Biomedical dismisses Prager Metis as auditor, engages KCCW

Dismissed Prager Metis CPAs as independent auditor effective June 30, 2025; no disagreements reported for 2024, 2023, or interim 2025.

Max materiality 0.70 · Median 0.60 · Most common event other_material

0 positive 1 negative 2 neutral